Forearm bone density in long-term users of oral combined contraceptives and depot medroxyprogesterone acetate

By Perrotti M.   Bahamondes L.   Petta C.   Castro S.  

Fertility and Sterility, Vol. 76, Iss. 3, 2001-09 ,pp. : 469-473

Elsevier

Access to resources Recommend Favorite

The association between depot medroxyprogesterone acetate contraception and bone mineral density in adolescent women

By Scholes D.   LaCroix A.Z.   Ichikawa L.E.   Barlow W.E.   Ott S.M.  

Contraception, Vol. 69, Iss. 2, 2004-02 ,pp. : 99-104

Elsevier

Access to resources Recommend Favorite

A pilot study examining short-term changes in bone mineral density among class 3 obese users of depot-medroxyprogesterone acetate

By Segall-Gutierrez Penina   Agarwal Reshem   Ge Marshall   Lopez Claudia   Hernandez Gerson   Stanczyk Frank Z.  

The European Journal of Contraception and Reproductive Health Care, Vol. 18, Iss. 3, 2013-06 ,pp. : 199-205

Informa Healthcare

Access to resources Recommend Favorite

Depot-medroxyprogesterone acetate in anticoagulated patients with previous hemorrhagic corpus luteum

By Sönmezer M   Atabekoğlu C   Cengiz B   Dökmeci F   Cengiz SD  

The European Journal of Contraception and Reproductive Health Care, Vol. 10, Iss. 1, 2005-03 ,pp. : 9-14

Informa Healthcare

Access to resources Recommend Favorite

The effects of a 3-month depot preparation of leuprorelin acetate on pain symptoms, bone mineral density and hormone levels in women with endometriosis—preliminary data analysis

By Baxter Niki   Duffy Sean  

Gynecological Surgery, Vol. 1, Iss. 2, 2004-06 ,pp. : 107-109

Springer Publishing Company

Access to resources Recommend Favorite